Lacklustre Performance Is Driving Sutro Biopharma, Inc.'s (NASDAQ:STRO) 36% Price Drop

Simply Wall StApr 18 06:30 ET

FDA Staff Cuts Are Already Impacting Regulatory Work, Biotech Leaders Warn

Seeking AlphaApr 10 11:37 ET

12 Health Care Stocks Moving In Monday's Intraday Session

BenzingaApr 7 13:05 ET

New Analyst Forecast: $STRO Given $2.0 Price Target

Quiver QuantitativeMar 18 14:21 ET

H.C. Wainwright Downgrades Sutro Biopharma(STRO.US) to Hold Rating, Cuts Target Price to $2

Moomoo NewsMar 18 03:31 ET · Ratings

This Li Auto Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

BenzingaMar 17 13:29 ET